Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantationLANCERS, P; CREMERS, S. C. L. M; DEN HARTIGH, J et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 5, pp 549-557, issn 0269-2813, 9 p.Article

Determining theTime Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using A Limited Sampling StrategyKATZENMAIER, S; MARKERT, C; RIEDEL, K.-D et al.Clinical pharmacology and therapeutics. 2011, Vol 90, Num 5, pp 666-673, issn 0009-9236, 8 p.Article

Validation of the limited-sampling models for carboplatin AUC in combination chemotherapy with taxanesMIYAZAKI, Mitsuru; OGURI, Tetsuya; KURATA, Takayasu et al.Anticancer research. 2004, Vol 24, Num 3B, pp 1911-1914, issn 0250-7005, 4 p.Article

Training in chorionic villus sampling: Limited experience for US fellowsJENKINS, Thomas M; SCISCIONE, Anthony C; WAPNER, Ronald J et al.American journal of obstetrics and gynecology. 2004, Vol 191, Num 4, pp 1288-1290, issn 0002-9378, 3 p.Article

Individualized population pharmacokinetic model with limited sampling for cyclosporine monitoring after liver transplantation in clinical practiceLANCERS, P; CREMERS, S. C. L. M; DEN HARTIGHT, J et al.Alimentary pharmacology & therapeutics. 2007, Vol 26, Num 10, pp 1447-1454, issn 0269-2813, 8 p.Article

Maximum a posteriori Bayesian estimation of epirubicin clearance by limited samplingRALPH, Lorraine D; THOMSON, Alison H; DOBBS, Nicola A et al.British journal of clinical pharmacology. 2004, Vol 57, Num 6, pp 764-772, issn 0306-5251, 9 p.Article

Analysis of small-scale biological compartments by capillary electrophoresisGOVINDARAJU, K; LLOYD, D. K.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 745, Num 1, pp 127-135, issn 1387-2273Conference Paper

A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycinFURTH, Alfred F; MANDREKAR, Sumithra J; TAN, Angelina D et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 1, pp 39-45, issn 0344-5704, 7 p.Article

A limited sampling method for the estimation of vigabatrin maximum plasma concentration and area under the curveTAMMARA, V; MAHMOOD, I; YU, D. K et al.Therapeutic drug monitoring. 1997, Vol 19, Num 1, pp 79-82, issn 0163-4356Article

Population pharmacodynamics : strategies for concentration- and effect-controlled clinical trialsEBLING, W. F; LEVY, G.The Annals of pharmacotherapy. 1996, Vol 30, Num 1, pp 12-19, issn 1060-0280Article

A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia aBOLON-LARGER, Magali; CHAMOUARD, Valérie; BRESSOLLE, Francoise et al.Therapeutic drug monitoring. 2007, Vol 29, Num 1, pp 20-26, issn 0163-4356, 7 p.Article

Limited Sampling Strategies to Estimate Exposure to the Green Tea Polyphenol, Epigallocatechin Gallate, in Fasting and Fed ConditionsFOSTER, David R; SOWINSKI, Kevin M; SHERRY CHOW, H. H et al.Therapeutic drug monitoring. 2007, Vol 29, Num 6, pp 835-842, issn 0163-4356, 8 p.Article

A limited sampling strategy for the estimation of 12-hour cyclosporine neoral area under the curve in Chinese cardiac transplant recipientsWANG, C. H; KO, W. J; CHOU, N. K et al.Transplantation proceedings. 2004, Vol 36, Num 8, pp 2390-2392, issn 0041-1345, 3 p.Conference Paper

A limited sampling method for the estimation of serum calcitriol area under the curve in cancer patientsMUINDI, Josephia R; WILSON, John W; YING PENG et al.Journal of clinical pharmacology. 2003, Vol 43, Num 8, pp 894-900, issn 0091-2700, 7 p.Article

Impact of random and fixed (optimal) sampling approach on the Bayesian estimation of clearanceMAHMOOD, I.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 9, pp 392-396, issn 0946-1965, 5 p.Article

Sparse-sampling algorithms and C2 monitoring are beneficial to optimize clinical outcomes for neoralWANG, X. H; TANG, X. D; XU, D et al.Transplantation proceedings. 2001, Vol 33, Num 1-2, pp 1059-1063, issn 0041-1345Conference Paper

Limited sampling model for the estimation of pharmacokinetic parameters in childrenMAHMOOD, Iftekhar.Therapeutic drug monitoring. 2000, Vol 22, Num 5, pp 532-536, issn 0163-4356Article

Prediction of the systemic exposure to oral 9-amino-20(S)-camptothecin using single-sample analysisSPARREBOOM, A; DE JONGE, M. J. A; PUNT, C. J. A et al.Drug metabolism and disposition. 1999, Vol 27, Num 7, pp 816-820, issn 0090-9556Article

Limited-sampling models for estimation of the carboplatin area under the curveMIYAZA, M; FUJIWARA, Y; TAKAHASHI, T et al.Anticancer research. 1997, Vol 17, Num 6D, pp 4571-4575, issn 0250-7005Article

A comparison of methods for limited-sampling strategy design using data from a phase I trial of the anthrapyrazole DuP-941JODRELL, D. I; MURRAY, L. S; HAWTOF, J et al.Cancer chemotherapy and pharmacology. 1996, Vol 37, Num 4, pp 356-362, issn 0344-5704Article

A Limited Sampling Model to Estimate Exposure to Lenalidomide in Multiple Myeloma PatientsSHIDA, Seiji; TAKAHASHI, Naoto; TAGAWA, Hiroyuki et al.Therapeutic drug monitoring. 2014, Vol 36, Num 4, pp 505-509, issn 0163-4356, 5 p.Article

Critical analysis and diagnostic usefulness of limited immunophenotyping of B-cell non-Hodgkin lymphomas by flow cytometryKALEEM, Zahid; WHITE, Glenda; VOLLMER, Robin T et al.American journal of clinical pathology. 2001, Vol 115, Num 1, pp 136-142, issn 0002-9173Article

Limited sampling model for area under the concentration time curve of total topotecanMINAMI, H; BEIJNEN, J. H; VERWEIJ, J et al.Clinical cancer research. 1996, Vol 2, Num 1, pp 43-46, issn 1078-0432Article

Evaluation of limited sampling strategies for tacrolimusOP DEN BUIJSCH, Robert A. M; VAN DE PLAS, Afke; STOLK, Leo M. L et al.European journal of clinical pharmacology. 2007, Vol 63, Num 11, pp 1039-1044, issn 0031-6970, 6 p.Article

Beyond cyclosporine : A systematic review of limited sampling strategies for other immunosuppressantsTING, Lillian S. L; VILLENEUVE, Eric; ENSOM, Mary H. H et al.Therapeutic drug monitoring. 2006, Vol 28, Num 3, pp 419-430, issn 0163-4356, 12 p.Article